Contemporary therapeutics and new drug developments for treatment of Fabry disease: a narrative review.

Oder, Daniel; Müntze, Jonas; Nordbeck, Peter

Oder, Daniel; Müntze, Jonas; Nordbeck, Peter.

Afiliación

Oder D; Department of Internal Medicine I, Fabry Center for Interdisciplinary Therapy (FAZIT) and Comprehensive Heart Failure Center (CHFC), University Hospital Würzburg, Würzburg, Germany.
Müntze J; Department of Internal Medicine I, Fabry Center for Interdisciplinary Therapy (FAZIT) and Comprehensive Heart Failure Center (CHFC), University Hospital Würzburg, Würzburg, Germany.
Nordbeck P; Department of Internal Medicine I, Fabry Center for Interdisciplinary Therapy (FAZIT) and Comprehensive Heart Failure Center (CHFC), University Hospital Würzburg, Würzburg, Germany.

Cardiovasc Diagn Ther ; 11(2): 683-695, 2021 Apr.

Article en En | MEDLINE | ID: mdl-33968645

Palabras clave

Fabry disease; chaperone therapy; enzyme replacement therapy; gene therapy; substrate reduction therapy

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Cardiovasc Diagn Ther Año: 2021 Tipo del documento: Article País de afiliación: Alemania

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google